RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Fwiw, the RSPI chart has shown a flat/truncated look at $4 over the past two months. I've seen similar charts in the past prior to financing announcements, where the financing entity maintains an upper cap on the share price during the pricing period. I haven't checked Level 2 to see if it shows a large standing sell order at $4, but even if it does, there could be other explanations other than a financing.

Also, there was an SEC filing that announced the resignation of RSPI's CFO (Weingarten) on Feb 17. May just be a coincidence, though perhaps it could be related to a coming financing or some other event. Wouldn't it be something if there's a change of ownership coming, so Weingarten decided to preemptively bail(?) Just a wild guess though, not trying to start any rumors. I guess time will tell.



https://www.sec.gov/Archives/edgar/data/849636/000149315217001873/form8-k.htm



>>> Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 17, 2017, Robert N. Weingarten informed the Board of Directors of RespireRx Pharmaceuticals Inc. (the “Company”) that he had decided to resign as a director, Vice President and Chief Financial Officer of the Company and its subsidiary, as of that date. Mr. Weingarten indicated that his resignation was for personal reasons, and the Company does not believe the resignation was the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The substance of the email that Mr. Weingarten sent regarding his resignation is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The Board of Directors, acting by written consent on February 22, 2017, appointed Jeff E. Margolis, the Company’s Vice president, Treasurer and Secretary, to act as the Company’s interim Chief Financial Officer. As an existing officer and director of the Company, information regarding Mr. Margolis is provided in the Company’s most recent Annual Report on Form 10-K, filed on March 29, 2016, and that information is incorporated herein by reference.

<<<